J. Medrano

发表

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

K. Shianna, D. Goldstein, J. Benito, 2010, AIDS.

Risk factors for advanced liver fibrosis in HIV‐infected individuals: role of antiretroviral drugs and insulin resistance

V. Soriano, J. González-lahoz, F. Blanco, 2011, Journal of viral hepatitis.

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV‐coinfected patients

V. Soriano, S. Rodríguez-Nóvoa, I. Jiménez-Nácher, 2011, Journal of viral hepatitis.

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.

R. Porcher, C. Delaugerre, J. Molina, 2011, The Journal of antimicrobial chemotherapy.

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

V. Soriano, S. Rodríguez-Nóvoa, F. Blanco, 2009, AIDS.

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

J. Benito, V. Soriano, J. McHutchison, 2011, The Journal of infectious diseases.

Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection.

V. Soriano, S. Rodríguez-Nóvoa, I. Jiménez-Nácher, 2010, The Journal of infectious diseases.

Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients.

V. Soriano, I. Jiménez-Nácher, S. Resino, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk for immune-mediated liver reactions by nevirapine revisited.

V. Soriano, F. Blanco, P. Labarga, 2008, AIDS reviews.

Viral hepatitis and HIV co-infection.

Pablo Barreiro, V. Soriano, Vincent Soriano, 2010, Antiviral research.

Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms.

E. Culebras, F. Baquero, J. Pérez-Díaz, 1986, The Journal of antimicrobial chemotherapy.

Survival of HIV-infected patients with compensated liver cirrhosis

V. Soriano, J. Del Amo, P. Labarga, 2010, AIDS.

Hepatitis B in HIV patients: what is the current treatment and what are the challenges?

V. Soriano, P. Labarga, P. Barreiro, 2009, Journal of HIV therapy.

Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/Hepatitis C Virus Coinfected Patients With Prior Nonresponse or Relapse

V. Soriano, S. Rodríguez-Nóvoa, P. Labarga, 2010, Journal of acquired immune deficiency syndromes.

[Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy].

V. Soriano, J. Medrano, 2009, Medicina clinica.

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

V. Soriano, J. González-lahoz, S. Rodríguez-Nóvoa, 2010, Antimicrobial Agents and Chemotherapy.

Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

Pablo Barreiro, Pablo Rivas, V. Soriano, 2010, Antiviral therapy.

Chikungunya infection in the general population and in patients with rheumatoid arthritis on biological therapy

R. Muñoz-Louis, J. Medrano, V. Rosario, 2015, Clinical Rheumatology.

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

J. Benito, V. Soriano, J. McHutchison, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

P. Vanhems, O. Kirk, R. Paredes, 2014 .

Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis

A. Boyer, S. Resino, M. Jiménez-Sousa, 2014, Critical Care.

HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

J. Benito, V. Soriano, J. Cosín, 2013, AIDS.

Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit

T. Kneib, A. Boyer, A. Alvaro-Meca, 2016, BMC Infectious Diseases.

Home treatment of deep venous thrombosis with low molecular weight heparin: Long‐term incidence of recurrent venous thromboembolism

J. M. Tenías, E. Grau, E. Real, 2001, American journal of hematology.

Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.

V. Soriano, N. Rallón, S. Resino, 2011, The Journal of infection.

Treatment of chronic hepatitis C in HIV‐infected patients with compensated liver cirrhosis

V. Soriano, J. González-lahoz, P. Labarga, 2011, Journal of viral hepatitis.

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

E. Poveda, V. Soriano, E. Seclén, 2010, AIDS.

Home treatment of deep venous thrombosis with low molecular weight heparin: Long‐term incidence of recurrent venous thromboembolism

E. Grau, E. Real, E. Pastor, 2001, American journal of hematology.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Direct testing of bronchoalveolar lavages from ventilator-associated pneumonia patients.

A. Boyer, D. Gruson, F. Vargas, 2012, Diagnostic microbiology and infectious disease.